RhumbLine Advisers’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-7,117
| Closed | -$376K | – | 3055 |
|
|
2020
Q3 | $376K | Sell |
7,117
-1,095
| -13% | -$67.6K | ﹤0.01% | 2421 |
|
|
2020
Q2 | $503K | Buy |
8,212
+578
| +8% | +$33.4K | ﹤0.01% | 2343 |
|
|
2020
Q1 | $432K | Hold |
7,634
| – | – | ﹤0.01% | 2231 |
|
|
2019
Q4 | $435K | Buy |
7,634
+59
| +0.8% | +$3.13K | ﹤0.01% | 2424 |
|
|
2019
Q3 | $405K | Sell |
7,575
-75
| -1% | -$4.37K | ﹤0.01% | 2423 |
|
|
2019
Q2 | $457K | Buy |
7,650
+344
| +5% | +$21.6K | ﹤0.01% | 2395 |
|
|
2019
Q1 | $455K | Sell |
7,306
-224
| -3% | -$14.8K | ﹤0.01% | 2365 |
|
|
2018
Q4 | $456K | Buy |
7,530
+2,492
| +49% | +$149K | ﹤0.01% | 2337 |
|
|
2018
Q3 | $295K | Sell |
5,038
-300
| -6% | -$15.3K | ﹤0.01% | 2519 |
|
|
2018
Q2 | $239K | Buy |
5,338
+355
| +7% | +$15.3K | ﹤0.01% | 2652 |
|
|
2018
Q1 | $221K | Sell |
4,983
-175
| -3% | -$7.35K | ﹤0.01% | 2571 |
|
|
2017
Q4 | $223K | Sell |
5,158
-1,619
| -24% | -$72.8K | ﹤0.01% | 2586 |
|
|
2017
Q3 | $315K | Buy |
6,777
+110
| +2% | +$5.27K | ﹤0.01% | 2534 |
|
|
2017
Q2 | $330K | Buy |
6,667
+466
| +8% | +$24.4K | ﹤0.01% | 2509 |
|
|
2017
Q1 | $340K | Buy |
6,201
+412
| +7% | +$21.8K | ﹤0.01% | 2445 |
|
|
2016
Q4 | $322K | Buy |
5,789
+439
| +8% | +$21.1K | ﹤0.01% | 2455 |
|
|
2016
Q3 | $244K | Buy |
5,350
+220
| +4% | +$8.84K | ﹤0.01% | 2584 |
|
|
2016
Q2 | $205K | Buy |
+5,130
| New | +$188K | ﹤0.01% | 2729 |
|
|
2016
Q1 | – | Sell |
-4,804
| Closed | -$206K | – | 3002 |
|
|
2015
Q4 | $206K | Buy |
+4,804
| New | +$241K | ﹤0.01% | 2784 |
|
Other funds holding BSTC
RhumbLine Advisers's BSTC Position: Q4 2020 in Review
RhumbLine Advisers sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 7,117 shares — an estimated $376K sold.
RhumbLine Advisers first reported a position in BSTC in Q4 2015 and held it in 19 quarters. The position peaked at $503K in Q2 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- RhumbLine Advisers reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- RhumbLine Advisers sold 7,117 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $376K.
- RhumbLine Advisers first reported a position in BioSpecifics Technologies Corp. in Q4 2015 and held it in 19 quarters.
- RhumbLine Advisers's BioSpecifics Technologies Corp. position peaked at $503K in Q2 2020.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on RhumbLine Advisers's 13F filing for Q4 2020, filed 10 Feb 2021.